A new doctrine could soon take hold in part of the US war on drugs: psychedelic drugs for active-duty soldiers suffering from PTSD.
In two studies funded by the Department of Defense (DoD), 186 service personnel with PTSD will likely next year undergo multiple sessions of MDMA-assisted therapy.
The deputy under secretary of war for personnel and readiness, Sean O’Keefe, is following the research closely, a January letter shows, and a new group of DoD and Veterans Affairs (VA) department therapists are to begin training in psychedelic-assisted therapy next week ahead of soldier enrollment.
It is hoped guided sessions with the euphoria-inducing drug could, perhaps counterintuitively, help soldiers fight for their country for longer – and that once they leave the military they will not be crippled by traumatic stress.
Military Glance
The world’s largest aircraft carrier, the USS Gerald R Ford, will be heading home following a record-setting deployment of more than 300 days that included participating in the war against Iran and capture of Venezuelan leader Nicolás Maduro, two US officials said Wednesday.
The U.S. has seized an Iranian-flagged cargo ship in the Strait of Hormuz after firing on its engine room, President Trump said in a post on social media.
Britain was an active participant in some Israeli war crimes in Gaza, a tribunal chaired by Your Party leader Jeremy Corbyn and two international law specialists has found.
A Washington DC grand jury declined to indict six Democratic lawmakers who were denounced by Donald Trump after they made a video urging troops to refuse illegal orders.





























